跳至主要内容
临床试验/NCT03796780
NCT03796780已完成不适用

Comparison of Effects of Extra-virgin and Refined Olive Oil Consumption on Plasma Lipids and Inflammatory Markers in Patients Undergoing Coronary Angiography

Javad Nasrollahzadeh2 个研究点 分布在 2 个国家目标入组 40 人开始时间: 2019年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40
试验地点
2
主要终点
Interleukin-6 (IL-6)

研究概览

简要总结

Consumption of extra-virgin olive oil has beneficial effects on cardiovascular risk factors. The purpose of this study is to compare the effects of extra-virgin olive oil and refined olive oil, in adjunct to conventional medical treatment, in improving liver enzymes, plasma lipid profile and inflammatory markers in patients with cardiovascular risk factors.

详细描述

A randomized placebo controlled clinical trial will be conducted in Rajaie Cardiovascular Center in Tehran, Iran. After review of the inclusion and exclusion criteria and explanation of the design of the study, written consent form will be completed. The participants are 40 eligible patients, aged 20-75 years. Intervention group will be received 25 mL/d extra-virgin olive oil and control group will be received 25 mL/d refined olive oil for 6 weeks. Fasting blood sample will be taken to measure lipid profile, liver enzymes and inflammatory markers (Interleukine-6 [IL-6] and Interleukine-10 [IL-10] and C-Reactive Protein [CRP]).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
20 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients with at least one of the cardiovascular risk factors (hypertension, hyperlipidemia, diabetes mellitus) candidate for angiography
  • willing to participation in the study

排除标准

  • Continuous consumption of any supplement with anti-inflammatory or antioxidant properties such as Omega-3, vitamin E, vitamin C and Selenium in last month
  • َChronic kidney disease stage 5
  • Any change in disease treatment plan such as change in type and dose of lipid lowering drugs or surgical operation

结局指标

主要结局

Interleukin-6 (IL-6)

时间窗: 6 week

change in plasma level of interleukin-6 (IL-6) in pg/mL from baseline at week-6

次要结局

  • plasma lipid profile(6 week)
  • Interleukin-10 (IL-10)(6 week)
  • C reactive protein (CRP)(6 week)
  • plasma liver enzymes (SGOT & SGPT)(6 week)

研究者

发起方
Javad Nasrollahzadeh
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Javad Nasrollahzadeh

Investigator in Clinical Nutrition

Shahid Beheshti University

研究点 (2)

Loading locations...

相似试验

Comparison of Extra-Virgin and Refined Olive Oil on... | 临床试验